Nexsen (ASX:NXN)
ASX announcement history & article coverage
Transparent by design.
Announcments by Nexsen (ASX:NXN) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notice of AGM and Meeting Materials
Professor Shekhar Kumta appointed Executive Director
Reinstatement to Quotation
Nexsen trading suspension to be lifted after proposed joint venture announcement
Proposed FlashDx joint venture builds on CE-marked GBS test
Nexsen proposes 50:50 FlashDx JV for enhanced molecular GBS test
Suspension from Quotation
Nexsen shares suspended pending announcement on potentially material device contract
Clear pathway defined to optimise StrepSure
Nexsen delays StrepSure FDA submission to optimise diagnostic performance
Trading Halt
Director Interest Notices re Performance Rights
Notification regarding unquoted securities - NXN
Notification regarding unquoted securities - NXN
Corporate Governance Statement and Appendix 4G
Annual Report - FY 2026
Nexsen reports $6.55 million loss in FY26, advances clinical trials and Asia-Pacific expansion post $8 million IPO
Quarterly Report - Q4 FY26
Nexsen advances Asia-Pacific strategy with hospital partnership, advisory appointment, and manufacturing funding